JPRN-UMIN000014889已完成未知
A randomized, parallel-group, double-blind study of transcranial direct-current stimulation (tDCS) for treatment-refractory auditory hallucinations in patients with schizophrenia - A randomized, double-blind study of transcranial direct-current stimulation (tDCS) for auditory hallucinations in schizophrenia
Department of Neuropsychiatry St. Marianna University School of Medicine0 个研究点目标入组 20 人开始时间: 2014年8月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 59years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Past history of traumatic brain injury with loss of conciousness 2)With cripping device or electrode of deep brain stimulation 3)With embedding cochlea stimulating device 4)With cardiac pacing device 5)Epilepsy and past history of epilepsy 6)Meeting DSM-IV-TR criteria for alcohol or other substance abuse or dpendence 7)Meeting DSM-IV-TR criteria for mental retardation or personality disorder 8)Past history of cerebrovascular disease 9)Severe neurological disease 10)Under treatment of severe infection disease or malignancy 11)Pregnant woman and under breast feeding 12)Active expression of suicidal ideation 13)Left-handed 14)Judged inappropriate to participate into the study by medical doctor
研究者
相似试验
已完成
不适用
A randomized, parallel-group, double-blind study of high-frequency, repetitive transcranial magnetic stimulation (rTMS) for schizophrenic patients with auditory hallucinations.Schizophrenia, Schizoaffective disorderJPRN-UMIN000006051Department of Psychiatry, Graduate School of Medicine, Chiba University40
进行中（未招募）
不适用
A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One TNF-InhibitorAdult Rheumatoid Arthritis (RA)MedDRA version: 13.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2010-023587-40-GRF. Hoffmann-La Roche Ltd.700
已完成
不适用
Rosemary anti-stress main studyhealthy personJPRN-UMIN000047500Clinical Creative Co., Ltd44
撤回
3 期
A randomized, double-blind, parallel-group study of the reduction of signs and symptoms during treatment with tocilizumab versus adalimumab, both in combination with MTX, in patients with moderate to severe active rheumatoid arthritis and an inadequate response to treatment with only one TNF inhibitor.RA1000381610023213rheumatoid arthritisNL-OMON36590Roche Nederland B.V.15
进行中（未招募）
1 期
A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One TNF-InhibitorAdult Rheumatoid Arthritis (RA)MedDRA version: 14.0Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2010-023587-40-DKF. Hoffmann-La Roche Ltd.700